Autonomix Medical, Inc. (NASDAQ:AMIX) Short Interest Down 29.7% in February

Autonomix Medical, Inc. (NASDAQ:AMIX) saw a large drop in short interest in the month of February. As of February 15th, there was short interest totalling 99,700 shares, a drop of 29.7% from the January 31st total of 141,900 shares. Based on an average daily volume of 377,400 shares, the short-interest ratio is presently 0.3 days. Currently, 8.0% of the shares of the company are short sold.

Autonomix Medical Stock Performance

NASDAQ AMIX opened at $2.38 on Tuesday. The firm has a market capitalization of $5.86 million and a P/E ratio of -0.18. Autonomix Medical has a fifty-two week low of $2.38 and a fifty-two week high of $82.00. The stock has a 50-day simple moving average of $2.99 and a two-hundred day simple moving average of $7.86.

Autonomix Medical (NASDAQ:AMIX) last posted its earnings results on Thursday, February 13th. The company reported ($1.46) earnings per share for the quarter. As a group, analysts forecast that Autonomix Medical will post -10 earnings per share for the current year.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Autonomix Medical stock. Citadel Advisors LLC bought a new stake in shares of Autonomix Medical, Inc. (NASDAQ:AMIX) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 47,884 shares of the company’s stock, valued at approximately $180,000. Citadel Advisors LLC owned 4.16% of Autonomix Medical as of its most recent SEC filing. 10.78% of the stock is currently owned by hedge funds and other institutional investors.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.